ASA: Less Bleeding Seen With Tenecteplase for Ischemic Stroke

FRIDAY, Feb. 4, 2022 -- For patients with ischemic stroke, use of tenecteplase (TNK) for thrombolysis is associated with a lower rate of symptomatic intracranial hemorrhage (sICH) than alteplase (ALT), according to a study presented at the American...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news